Search All News
Dystonia, when muscles contract uncontrollably, would be disconcerting to anyone, but it can be a career-ending disorder for trained musicians.
Even in people with complete paralysis after spinal cord injury, some nerves fibers are preserved. A Columbia physician-scientist is developing a new way to salvage those fibers and restore movement.
To treat a young child with an ultrarare neurological disorder, her Columbia doctor has turned to a custom drug designed for a single patient.
- May 10, 2022
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
- March 30, 2022
Parkinson’s patients and their families are increasingly turning to genetic testing to learn more about their disease or risk of passing it on. But testing is complex, and counseling is advised.
- March 15, 2022
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
- March 7, 2022
A newly discovered protein tangle has been associated with multiple neurodegenerative diseases and may have a role in causing the diseases.
- February 15, 2022
One of the cell's most common proteins may become too old and too stable in Alzheimer’s disease, altering neuronal activity and impairing memory.
- November 11, 2021
A study of more than 500 hospitalized COVID patients found that comorbidities do not necessarily result in the worst outcomes.
- November 1, 2021
Since 1955, “Merritt’s Neurology,” edited by Columbia neurologists, has been regarded as the standard reference work in the field. James Noble, MD, joins the ranks for the latest edition.
- October 27, 2021
New technology will allow scientists to uncover what happens in the brain during the early stages of Parkinson's disease, which could lead to earlier diagnosis and better therapies for the disease.